Literature DB >> 1838257

An activating amino acid substitution in the c-abl oncogene protein fails to produce a local conformational change.

P W Brandt-Rauf1, G Bomzer, D Belford, M R Pincus.   

Abstract

The bcr-abl chimeric gene of Philadelphia chromosome positive chronic myelogenous leukemias is only weakly transforming. This transformation activity is greatly enhanced by a Lys-for-Glu substitution at position 832 in the c-abl gene, as occurs in the highly transforming v-abl genes. It has been suggested that this mutation results in a significant structural change in the encoded protein product. Using conformational energy analysis, we have determined the allowed low-energy conformations for residues 828-836 of this protein with Lys and Glu at position 832. In both cases, the overwhelmingly preferred conformation for this region is a bend-helix motif. The helix terminates at residue 836, and there are no discernible differences in conformation between the Lys- and Glu-containing sequences. These results suggest that the activating amino acid substitution at position 832 in the c-abl protein product does not produce its effect via a local conformational change.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838257     DOI: 10.1007/bf01025258

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  16 in total

1.  Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.

Authors:  S K Shore; S L Bogart; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Correlation of beta-bend conformations of tetrapeptides with their activities in CD4-receptor binding assays.

Authors:  D Shah; J M Chen; R P Carty; M R Pincus; H A Scheraga
Journal:  Int J Pept Protein Res       Date:  1989-10

3.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

4.  Conformational analysis of the 20 naturally occurring amino acid residues using ECEPP.

Authors:  S S Zimmerman; M S Pottle; G Némethy; H A Scheraga
Journal:  Macromolecules       Date:  1977 Jan-Feb       Impact factor: 5.985

5.  Calculation of the three-dimensional structure of the membrane-bound portion of melittin from its amino acid sequence.

Authors:  M R Pincus; R D Klausner; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Use of a symmetry condition to compute the conformation of gramicidin S1.

Authors:  M Dygert; N Gō; H A Scheraga
Journal:  Macromolecules       Date:  1975 Nov-Dec       Impact factor: 5.985

7.  Structural effects of substitutions on the p21 proteins.

Authors:  M R Pincus; P W Brandt-Rauf
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.

Authors:  J McLaughlin; E Chianese; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

9.  Nucleotide sequence analysis of human abl and bcr-abl cDNAs.

Authors:  E Fainstein; M Einat; E Gokkel; C Marcelle; C M Croce; R P Gale; E Canaani
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

10.  Conformational effects of substituting amino acids for glutamine-61 on the central transforming region of the P21 proteins.

Authors:  M R Pincus; P W Brandt-Rauf; R P Carty; J Lubowsky; M Avitable; K D Gibson; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  1 in total

1.  Conformational effects of environmentally induced, cancer-related mutations in the p53 protein.

Authors:  P W Brandt-Rauf; R Monaco; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.